Inventiva (IVA)
(Delayed Data from NSDQ)
$2.68 USD
-0.05 (-1.65%)
Updated Jul 12, 2024 03:43 PM ET
After-Market: $2.73 +0.05 (1.87%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IVA 2.68 -0.05(-1.65%)
Will IVA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for IVA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IVA
Down -27.95% in 4 Weeks, Here's Why You Should You Buy the Dip in Inventiva (IVA)
Humana (HUM) Ups '23 Medicare Advantage Membership Growth View
IVA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why You Should Retain Centene (CNC) in Your Portfolio Now
What You Need to Know From UnitedHealth's (UNH) Latest Outlook
Cigna (CI) Rises 18.9% in 6 Months: More Growth in Store?
Other News for IVA
Inventiva provides an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position
Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 2024
Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024
Inventiva Shareholders Approve Key Resolutions
Inventiva Launches Share Repurchase Program